Long-term assessment of the immunological response to hepatitis B vaccines in 136 haemodialysis patients;Evaluación a largo plazo de la respuesta inmunológica a la vacuna de la hepatitis B en 136 pacientes en hemodiálisis

Nefrologia

Volumn 29, Issue 5, 2009, Pages 415-420

  Pin, M ^a   Compte, M T ^a   Angelet, P ^a   Gallego C ^a   Gutierrez C ^b   Vea, A Martínez ^b  

^a Santa Creu Hospital   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Hemodialysis; Hepatitis B; Seroprotection; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TIME;

AGED; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 72949088479     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/NEFROLOGIA.2009.29.5.5349.EN.FULL     Document Type: Article

References (24)

1. European best practice guidelines for haemodialysis. Section VI. Haemodialysis-associated infection. Nephrol Dial Transplant 2002;17(7):72-87.
2. Barril G, González Parra E, Alcaraz R, Arenas D, Campistol JM, Caramelo C, et al. Guía sobre enfermedades víricas en hemodiálisis. Nefrología 2004; 24(2):43-66.
3. Daroza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better. Am J Kidney Dis 2003;42:1184-92.
4. Fabrizi F, Bunnapradis S, Martin P. HBV infection in patients with end-stage renal disease. Semin Liver Dis 2004;24(1):63-70.
5. Tang S, Lai KN. Chronic viral hepatitis in hemodialysis patients. Hemodial Int 2005;9:169-79.
6. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 1984;311:496-501.
7. Buti M, Viladomiu L, Jardi R, Olmos A, Rodríguez JA, Bartolomé J, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992;12:144-7.
8. Recommendations for preventing transmission of infections among chronic hemodialysis patients. Centres for Disease Control and Prevention. MMWR Recomm Rep 2001;50(RR-5):1-43.
9. Peces R. Inmunización frente a la hepatitis B y persistencia de memoria inmunológica. Nefrología 2002;22:503-6.
10. Litjens NHR, Huisman M, van den Dorpel M, Betjes MGH. Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. J Am Soc Nephrol 2008;19:1483-90.
11. Chow KM, Law MC, Leung CB, Szeto CC, Li PK. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract 2006;103:c87-c88.
12. Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B-re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Tranplant 1997;12:1204-11.
13. Kong NCT, Beran J, Kee SA, Miguel JL, Sánchez C, Bayas JM, et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int 2008;73:856-62.
14. Schroth R, Hitchon C, Uhanova J, Noreddin A, Taback SP, Moffatt ME, et al. Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database Syst Rev 2004;3:CD003775.
15. Rangel MC, Coronado VG, Euler GL, Strikas RA. The Advisory Comité on Immunization Practices and the American Academy of Pediatrics. Vaccine recommendations for patients on chronic dialysis. Semin Dial 2000;13:101-7.
16. Dinits-Pensy M, Forrest GN, Cross AS, Hise MK. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 2005;46:997-1011.
17. Finelli L, Millar JT, Tokars JI, Alter MJ, Arduino MJ. Nacional Surveillance of dialysis-associated diseases in the United Status, 2002. Semin Dial 2005;18:52-61.
18. Peces R, Laurés AS. Persistente of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response. Nephron 2001;89:172-6.
19. Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or alter vaccination. Clin Nephrol 2007;68:228-34.
20. Unger JK, Peters H. Hepatitis B in chronic kidney disease: Moving toward effective prevention. Kidney Int 2008;73:799-801.
21. Chiaramonte M, Ngatchu T, Majori S, Baldo V, Moschen ME, Renzulli G, et al. Response to an extra dose of hepatitis B vaccine and specific antibody persistente in non-responders to primary immunisation. Scand J Gastroenterol 1995;30:601-3.
22. Charest AF, McDougall J, Goldstein MB. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000;36:976-82.
23. Beaulieu M, Krajden M, Buxton J, Er L, Djurdjev O, Levin A. Variability of hepatitis B testing in British Columbian ESRD patients: the case to focus on implementation of guidelines. Am J Kidney Dis 2008;52:939-46.
24. Davis JP. Experience with hepatitis A and B vaccines. Am J Med 2005;118(10A):7S-15S.